We’re adding to our position in this out-of-favor, high-quality drugmaker stock
- Posted on May 22, 2025
- By CNBC
- 2 Views
We’re adding to our position in this out-of-favor, high-quality drugmaker stock
With shares trading at a 52-week low and only 24 times its estimated 2026 EPS, many risks have already been priced in.
